About
Avicenna is a biotechnology company integrating advanced molecular biology, bioprocess engineering and analytical sciences to produce high-value bioactive molecules derived from plant and microbial systems. Its laboratories support controlled extraction, purification and characterisation workflows, including the scalable production of natural active ingredients such as oleuropein.
The organisation’s competencies span analytical chemistry, microbiology, recombinant biomolecule development, postbiotic and extracellular vesicle bioproduction, and data-driven diagnostic research supported by artificial intelligence. These capabilities are anchored in an extensive scientific foundation covering discovery, experimental validation, process optimisation and scale-up readiness.
Operating as an integrated R&D and production platform, Avicenna combines academic-grade methodological depth with applied industrial processes to deliver reliable biotechnological solutions relevant to pharmaceuticals, nutraceuticals, diagnostics and sustainable bio-based value chains.